FDA Approved: SUMATRIPTAN — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved Bionpharma Inc.'s generic Sumatriptan via an Original Application (ANDA) for the treatment of acute migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan (Sumatriptan)

Snippet

ORIG AP for SUMATRIPTAN (SUMATRIPTAN)